Leukotriëenreceptorantagonisten

Leukotriëenreceptorantagonisten is a class of medications used primarily to treat asthma and allergic rhinitis. These drugs work by blocking the action of leukotrienes, which are inflammatory substances produced by the body. Leukotrienes contribute to the inflammation, bronchoconstriction (narrowing of the airways), and mucus production that characterize conditions like asthma. By inhibiting these effects, leukotriëenreceptorantagonisten help to reduce airway inflammation and alleviate symptoms such as wheezing, shortness of breath, and nasal congestion.

Commonly prescribed leukotriëenreceptorantagonisten include montelukast, zafirlukast, and zileuton. They are typically taken orally as tablets or granules. While generally well-tolerated, potential side effects can include headache, abdominal pain, and, in rare cases, neuropsychiatric symptoms. These medications are not rescue inhalers and are intended for long-term control of chronic inflammatory airway diseases, not for immediate relief of acute asthma attacks. Their effectiveness can vary between individuals, and they are often used in conjunction with other asthma medications.